Hutchmed (China) Limited
HCM
ISIN null / Valor 30165904
Hutchmed (China) Limited
UMushroom community rating:
About company
Hutchmed (China) Limited is the China-focused arm of Hutchison China MediTech, a research-driven biopharmaceutical company that discovers, develops and commercializes targeted therapies and immunotherapies primarily for oncology and immunological diseases. The company combines in-house discovery and clinical development with a commercial organization in China to bring small molecules and biologics from early-stage research through registration and market launch, and maintains a pipeline of clinical-stage candidates across multiple indications. Hutchmed also engages in strategic collaborations and out-licensing with international partners to support late-stage development and global commercialization.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
2572 M
Market cap (USD)
28,847
Daily traded volume (Shares)
14.45 / 14.17
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
